NHC
National HealthCare Corporation · Healthcare · Medical - Care Facilities
Momentum inputs (comparable managers):
holder breadth -30.0% ·
share flow -5.4% ·
net new positions -20.0%
— formula
Broad distribution — falling shares and fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q4 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 84 | +5 | 7.12M | $1.51B | +9 | −4 |
| Q1 2026 | 82 | -2 | 6.91M | $1.10B | +4 | −6 |
| Q4 2025 | 84 | 0 | 7.44M | $1.02B | +1 | −1 |
| Q3 2025 | 14 | -2 | 4.85M | $590.24M | — | −2 |
| Q2 2025 | 13 | +1 | 4.66M | $498.80M | +1 | — |
| Q1 2025 | 9 | +2 | 1.32M | $122.67M | +2 | — |
| Q4 2024 | 7 | -4 | 1.24M | $133.72M | — | −4 |
| Q3 2024 | 10 | +1 | 803.83K | $101.11M | +1 | — |
| Q2 2024 | 9 | — | 813.70K | $88.21M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passive) | 506.95K | — | $54.83M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Renaissance Technologies ✦ | 381.87K | -2.4% | $41.07M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passive) | 288.66K | -1.3% | $31.06M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passive) | 288.66K | -1.3% | $31.06M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 5 | Arrowstreet Capital ✦ | 26.88K | -51.6% | $2.89M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 6 | AQR Capital Management ✦ | 15.82K | -30.2% | $1.70M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 7 | AQR Capital Management ✦ | 15.82K | -30.2% | $1.70M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 8 | Millennium Management ✦ | 13.14K | -44.1% | $1.41M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | T. Rowe Price ✦ | 6.94K | +15.9% | $747,000 | 0.0% | ▲ Add | 3 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| Bridgewater Associates | $619,795 | was 0.0% |
| Marshall Wace | $377,310 | was 0.0% |
| Citadel Advisors | $287,007 | was 0.0% |
| Gotham Asset Management | $269,022 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 236 holders, 10.21M shares, $1.54B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer, Director · 1.50K sh · $355,620
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology